Gracell Biotechnologies Overview

Gracell Biotechnologies Other Income Expense Net

Other Income/Expense Net for GRCL.

Quarterly Other Income/Expense

$45.53M

↑ 2224.45% YoY

As of Sep 30, 2023

Annual Other Income/Expense (TTM)

$69.72M

↑ 845.3% YoY

Trailing 12 months ending Sep 30, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin